Back to questions

Thanks for the question. I think we have more work to do to know the best way to improve structural variation detection. There is potential in thinking about the pan genome approach and I think it is important to explore this. However, it may be that using de novo assembly for analyzing genomes may be the best way to identify structural variation. There is a lot of work going on in both areas and hopefully we'll have more data on the optimal approaches within the next couple of years.


No comments yet.

The questions, answers and comments posted under this Expert Q&A forum reflect the views of the author(s) and should not be construed to represent views or policies held by the FDA. Experts answer questions at their discretion and thus not all questions may be addressed. The Expert Q&A forum is also not intended to address questions pertaining to medical advice, diagnosis or treatment.